Ben Goldacre is a self- confessed nerd ;) He is also fascinated by epidemiology and the stats and numbers surrounding various medical treatments and interventions.
He is the author of a book called Bad Science an informative book critical of the reporting of science and medicine in the media, and the various distortions and misrepresentations this leads to. Well worth reading.
He is also set to publish a new bool, called Bad Pharma, of which this article is an exerpt.
He raises valid points. The regulatory system around the globe is only as good as the data it gets to see - and all too often, companies suppress negative data because of the commercial implications.Various meta- analyses have demonstrated that industry sponsored trials almost invariably have much more positive findings than similar trials conducted independently.
And this can do serious harms. Prescribing a medical intervention is informed in part by a proper consideration of the risk of side effects or non treatment versus the supposed benefit of the intervention. If these benefits are overstated, or negative results suppressed to skew the data, this can lead to very serious consequences for the millions of patients around the globe.
Many people might remember the scandal surrounding GSKs Avandia ( mentioned in the article by Ben Goldacre) that significantly increased the risk of heart attack in the patients it was prescribed for - by around 40%!
http://healthland.tim...on-dollar-wrongdoing/
The more people that recognise the problems the better, and the sooner we change the international regulatory environment to force companies to register proposed drug trials and publish all their trial data the healthier we all will be......